Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis

George V. Papatheodoridis, John Goulis, Gioacchino Leandro, David Patch, Andrew K. Burroughs

Research output: Contribution to journalArticle

Abstract

Endoscopic treatment (ET) is frequently used to prevent variceal rebleeding but this still occurs in about 50% of patients. Recently, transjugular intrahepatic portosystemic shunt (TIPS) has been compared with ET in several trials. Using a meta-analysis, we evaluated randomized trials comparing TIPS to ET assessing prevention of rebleeding, survival, and the effects on resource use and the quality of patients' lives. Medical databases were searched between January 1988 and January 1999 as well as published citations and conference proceedings. Sensitivity analyses for type of publication, methodological quality score, mean duration of follow-up, type of ET, etiology, and severity of liver disease were performed. Eleven randomized trials involving 811 patients fulfilled the selection criteria. The median follow-up ranged from 10 to 32 months. Variceal rebleeding was significantly more frequent with ET (47%) compared with TIPS (19%) (odds ratio [OR], 3.8; 95% confidence interval [CI], 2.8-5.2; P <.001), but there was no difference in mortality (OR, 0.97; 95% CI, 0.71-1.34). Post-treatment encephalopathy occurred significantly less often after ET (19%) than after TIPS (34%) (OR, 0.43; 95% CI, 0.30-0.60; P <.001). In the studies showing resource use this was more extensive for TIPS. The sensitivity analyses did not alter the main conclusion, and sole comparison with endoscopic ligation did not alter these results. In conclusion, in patients with variceal bleeding, TIPS compared with ET reduces the rebleeding rate, but does not improve survival, and increases the incidence of encephalopathy in a period of 1 to 2.5 years. Thus, TIPS cannot be recommended as the first choice treatment for prevention o f variceal rebleeding.

Original languageEnglish
Pages (from-to)612-622
Number of pages11
JournalHepatology
Volume30
Issue number3
DOIs
Publication statusPublished - 1999

Fingerprint

Transjugular Intrahepatic Portasystemic Shunt
Meta-Analysis
Therapeutics
Odds Ratio
Brain Diseases
Confidence Intervals
Patient Selection
Survival
Ligation
Publications
Liver Diseases
Databases
Hemorrhage

ASJC Scopus subject areas

  • Hepatology

Cite this

Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding : A meta-analysis. / Papatheodoridis, George V.; Goulis, John; Leandro, Gioacchino; Patch, David; Burroughs, Andrew K.

In: Hepatology, Vol. 30, No. 3, 1999, p. 612-622.

Research output: Contribution to journalArticle

Papatheodoridis, George V. ; Goulis, John ; Leandro, Gioacchino ; Patch, David ; Burroughs, Andrew K. / Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding : A meta-analysis. In: Hepatology. 1999 ; Vol. 30, No. 3. pp. 612-622.
@article{038196baa51a48188be3a3c15d46826a,
title = "Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis",
abstract = "Endoscopic treatment (ET) is frequently used to prevent variceal rebleeding but this still occurs in about 50{\%} of patients. Recently, transjugular intrahepatic portosystemic shunt (TIPS) has been compared with ET in several trials. Using a meta-analysis, we evaluated randomized trials comparing TIPS to ET assessing prevention of rebleeding, survival, and the effects on resource use and the quality of patients' lives. Medical databases were searched between January 1988 and January 1999 as well as published citations and conference proceedings. Sensitivity analyses for type of publication, methodological quality score, mean duration of follow-up, type of ET, etiology, and severity of liver disease were performed. Eleven randomized trials involving 811 patients fulfilled the selection criteria. The median follow-up ranged from 10 to 32 months. Variceal rebleeding was significantly more frequent with ET (47{\%}) compared with TIPS (19{\%}) (odds ratio [OR], 3.8; 95{\%} confidence interval [CI], 2.8-5.2; P <.001), but there was no difference in mortality (OR, 0.97; 95{\%} CI, 0.71-1.34). Post-treatment encephalopathy occurred significantly less often after ET (19{\%}) than after TIPS (34{\%}) (OR, 0.43; 95{\%} CI, 0.30-0.60; P <.001). In the studies showing resource use this was more extensive for TIPS. The sensitivity analyses did not alter the main conclusion, and sole comparison with endoscopic ligation did not alter these results. In conclusion, in patients with variceal bleeding, TIPS compared with ET reduces the rebleeding rate, but does not improve survival, and increases the incidence of encephalopathy in a period of 1 to 2.5 years. Thus, TIPS cannot be recommended as the first choice treatment for prevention o f variceal rebleeding.",
author = "Papatheodoridis, {George V.} and John Goulis and Gioacchino Leandro and David Patch and Burroughs, {Andrew K.}",
year = "1999",
doi = "10.1002/hep.510300316",
language = "English",
volume = "30",
pages = "612--622",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding

T2 - A meta-analysis

AU - Papatheodoridis, George V.

AU - Goulis, John

AU - Leandro, Gioacchino

AU - Patch, David

AU - Burroughs, Andrew K.

PY - 1999

Y1 - 1999

N2 - Endoscopic treatment (ET) is frequently used to prevent variceal rebleeding but this still occurs in about 50% of patients. Recently, transjugular intrahepatic portosystemic shunt (TIPS) has been compared with ET in several trials. Using a meta-analysis, we evaluated randomized trials comparing TIPS to ET assessing prevention of rebleeding, survival, and the effects on resource use and the quality of patients' lives. Medical databases were searched between January 1988 and January 1999 as well as published citations and conference proceedings. Sensitivity analyses for type of publication, methodological quality score, mean duration of follow-up, type of ET, etiology, and severity of liver disease were performed. Eleven randomized trials involving 811 patients fulfilled the selection criteria. The median follow-up ranged from 10 to 32 months. Variceal rebleeding was significantly more frequent with ET (47%) compared with TIPS (19%) (odds ratio [OR], 3.8; 95% confidence interval [CI], 2.8-5.2; P <.001), but there was no difference in mortality (OR, 0.97; 95% CI, 0.71-1.34). Post-treatment encephalopathy occurred significantly less often after ET (19%) than after TIPS (34%) (OR, 0.43; 95% CI, 0.30-0.60; P <.001). In the studies showing resource use this was more extensive for TIPS. The sensitivity analyses did not alter the main conclusion, and sole comparison with endoscopic ligation did not alter these results. In conclusion, in patients with variceal bleeding, TIPS compared with ET reduces the rebleeding rate, but does not improve survival, and increases the incidence of encephalopathy in a period of 1 to 2.5 years. Thus, TIPS cannot be recommended as the first choice treatment for prevention o f variceal rebleeding.

AB - Endoscopic treatment (ET) is frequently used to prevent variceal rebleeding but this still occurs in about 50% of patients. Recently, transjugular intrahepatic portosystemic shunt (TIPS) has been compared with ET in several trials. Using a meta-analysis, we evaluated randomized trials comparing TIPS to ET assessing prevention of rebleeding, survival, and the effects on resource use and the quality of patients' lives. Medical databases were searched between January 1988 and January 1999 as well as published citations and conference proceedings. Sensitivity analyses for type of publication, methodological quality score, mean duration of follow-up, type of ET, etiology, and severity of liver disease were performed. Eleven randomized trials involving 811 patients fulfilled the selection criteria. The median follow-up ranged from 10 to 32 months. Variceal rebleeding was significantly more frequent with ET (47%) compared with TIPS (19%) (odds ratio [OR], 3.8; 95% confidence interval [CI], 2.8-5.2; P <.001), but there was no difference in mortality (OR, 0.97; 95% CI, 0.71-1.34). Post-treatment encephalopathy occurred significantly less often after ET (19%) than after TIPS (34%) (OR, 0.43; 95% CI, 0.30-0.60; P <.001). In the studies showing resource use this was more extensive for TIPS. The sensitivity analyses did not alter the main conclusion, and sole comparison with endoscopic ligation did not alter these results. In conclusion, in patients with variceal bleeding, TIPS compared with ET reduces the rebleeding rate, but does not improve survival, and increases the incidence of encephalopathy in a period of 1 to 2.5 years. Thus, TIPS cannot be recommended as the first choice treatment for prevention o f variceal rebleeding.

UR - http://www.scopus.com/inward/record.url?scp=0032858182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032858182&partnerID=8YFLogxK

U2 - 10.1002/hep.510300316

DO - 10.1002/hep.510300316

M3 - Article

C2 - 10462365

AN - SCOPUS:0032858182

VL - 30

SP - 612

EP - 622

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 3

ER -